Neurolens
Latest round
- Series E
Last raised
- Sep 2022
Total raised
- $68M
Investors
- 3
About Neurolens
Neurolens, Inc.Founded in 2012 in Coppell, Texas, Neurolens, Inc. specializes in addressing eye misalignment through its unique lens technology.Neurolens specializes in advanced eye misalignment treatment through its innovative product offerings, primarily focusing on contoured prism lenses designed to alleviate a variety of debilitating symptoms associated with eye misalignment. These lenses aim to provide relief from headaches, eye strain, neck and shoulder pain, dizziness, dry eye, and light sensitivity. The company's core product, Neurolens, employs a unique technology that incorporates contoured prism technology to restore comfortable alignment of the eyes, thereby enhancing visual comfort and overall quality of life for patients. Neurolens primarily targets adults, as studies indicate that up to 80% of this demographic experiences issues related to eye misalignment.Neurolens operates on a business model that includes both direct-to-consumer and B2B transactions, where the company partners with optometrists and eye care professionals to distribute its products. The transaction structure typically involves optometrists recommending Neurolens to patients who are experiencing symptoms of eye misalignment and subsequently providing the lenses during consultations. This model fosters a collaborative approach to patient care, ensuring that consumers receive tailored solutions for their eye health needs. While specific pricing details for Neurolens products are not disclosed, the company likely offers various pricing plans that cater to both individual consumers and optometry practices. This expansion aims to enhance their product offerings and reach more patients suffering from eye misalignment issues.
Who invested in Neurolens
3 investors across 1 round
See all investors in Neurolens
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Sep 1, 2022
Amount
$68M
Investors
Questions about Neurolens
Who invested in Neurolens?
Neurolens has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurolens raised?
Neurolens has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neurolens last raise money?
Neurolens's most recent round on record is a Series E, in Sep 2022.
What does Neurolens do?
Neurolens is a medical devices & equipment company.
Where is Neurolens headquartered?
Neurolens is headquartered in Coppell, US.
Which VCs invest in companies like Neurolens?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Neurolens's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series E
Raising like Neurolens? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.